Mucosal Environment and HIV Prevention (MEHP) (R01)

The summary for the Mucosal Environment and HIV Prevention (MEHP) (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Mucosal Environment and HIV Prevention (MEHP) (R01): The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, encourages grant applications from institutions/organizations that address the long term goal and objectives of increasing the safety and efficacy of non-vaccine biomedical prevention, such as microbicides and PrEP, through a better understanding of their interactions with the tissue micro- and macro-environments of the genital (male and female) and gastrointestinal mucosa.

Federal Grant Title:	Mucosal Environment and HIV Prevention (MEHP) (R01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-12-106
Type of Funding:	Grant
CFDA Numbers:	93.855
CFDA Descriptions:	Allergy, Immunology and Transplantation Research
Current Application Deadline:	Jan 07, 2013
Original Application Deadline:	Jan 07, 2015
Posted Date:	Feb 14, 2012
Creation Date:	Oct 19, 2012
Archive Date:	Feb 07, 2013
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed); • Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed); • Promoting Innovative Research in Treponema pallidum Pathogenesis (R21 Clinical Trial Not A...; • Novel Approaches for Radiation Biodosimetry and Medical Countermeasure Development (R21 Cl...; • Halting Tuberculosis (TB) Transmission (R01 Clinical Trial Optional); • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health: • Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed...; • Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional); • NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational R...; • Clinical and Translational Science Award (UM1 Clinical Trial Optional); • Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Pro...